Dr. Ryan D'Arcy: 00:00
We're writing up the second paper to follow now because these students go home for summer and then they come back. So we would measure them before and after contact sport and then actually do another assessment when they got back after a break in the summer. And um without uh obviously going too deep into the science because I don't want to spoil the paper, but Welcome to Life After Impact, the concussion recovery podcast.
Dr. Ayla Wolf DAOM: 00:25
I'm Dr. Ayla Wolf, and I will be hosting today's episode where we help you navigate the often confusing, frustrating, and overwhelming journey of concussion and brain injury recovery. This podcast is your go-to resource for actionable information. Whether you're dealing with a recent concussion, struggling with post-concussion syndrome, or just feeling stuck in your healing process, know that you are not alone. This podcast can be your guide and partner in recovery, helping you build a better life after impact.
Dr. Ayla Wolf DAOM: 00:57
Dr. Ryan Darcy, welcome to the show.
Dr. Ryan D'Arcy: 01:00
Thanks for having me.
Dr. Ayla Wolf DAOM: 01:02
Yes, you are the co-founder, president, and chief scientific officer of Health Tech Connects, which creates a very fascinating device called Neurocatch, which I am excited to hear a lot more about. And your work spans neuroimaging, neurotechnology, brain injury, neuroplasticity. You've got many, many peer-reviewed publications and over $100 million in research funding. You pioneered this concept of brain vital signs. I would love for you to give a little bit about your background, how you got into this, and then what exactly you mean when you talk about uh brain vital signs.
Dr. Ryan D'Arcy: 01:42
For sure. Yeah. So uh my background is trained in neuroscience. Uh, and as you mentioned, uh specifically in uh human neuroimaging, I've spent my career building and running uh large institutes and labs uh in in imaging. I've often joked that I uh if you I would peer inside your brain and watch your brain in action using advanced technology. So it intersects a lot with uh physics and engineering as well. And uh the a lot of my work has uh, well, a lot of it has actually been very hardcore fundamental neuroscience and neuroimaging. Um, I've always had this real drive for translational impact. So I wanted the stuff that we were doing in these really advanced labs to get out in the world and help people. And so uh one of our major areas has been looking at using uh EEG-based technology uh and getting objective measurements of cognitive function through a very long-standing capability in labs called evoked potentials or event-related potentials. And the problem is they were buried in the lab. So we were working on this as a scientific problem for a long time. How could we get them out in the outside world? And that's where brain vital signs came from. There was a there was a moment, uh almost a eureka moment, where it was like, wait a minute, why is there not a vital sign for your brain? We have vital signs for everything,
Dr. Ryan D'Arcy: 03:10
but not your brain. So we got to work in the lab of it was a scary challenge, to be honest. Um, and I can tell you why. Um, but we really got to work in the lab of of reverse engineering and coming up with a framework for vital signs for your brain. And that's how Neurocatch was born.
Dr. Ayla Wolf DAOM: 03:28
Amazing. And Neurocatch is different from other EEG devices. Can you talk a little bit about what makes it unique?
Dr. Ryan D'Arcy: 03:35
Sure. There's lots of things. It's like having another child. You asked me to talk about my baby, I'll talk about them all the all day long. Um, Neurocatch is unique in the sense that we focused on clinical uh frontline applications. So we took what would take me in the lab about two to three hours and we compressed that down to six minutes. And we also took uh the sort of the dependency of experts and technical people right out of the equation by automating it. So it's push button. So you push a button and uh six minutes and 15 seconds later you get the result. And that actually did a couple of things that meant that whether or not I do it or you do it, or we've had high school students do it, uh, you get the same standardized clinical result, which is quite uh really, I think, important. The other aspect of it is that it allows for the standardization for us to do both a normative comparison. So, like a blood pressure cuff, I can compare your individual results against a norm and see where you map. Uh, but also it it allows um for the ability to actually monitor your changes over time, which is really important. So, so effectively by reverse engineering a vital sign framework, we made Neurocatch unique in that it's the only device that you can really quickly and easily get an assessment of an objective assessment of your cognitive brain functioning. That makes it pretty special.
Dr. Ayla Wolf DAOM: 05:07
Yes. And when you say that you're comparing it against normative values, are those different based on age or how are you and how many people were measured in order to collect the normative data?
Dr. Ryan D'Arcy: 05:20
Sure. So we're data snobs uh and we always want the best data. Worldwide, I think we've done more than 31,000 scans, but we actually curate a very honed normative database. So we we collect our normative data under really strict, rigorous scientific. And that means we have about 400 scans now from the ages of about eight to 85 that characterize like healthy brain function and what that profile looks like. And then when we do a scan, we can do a comparison of your scan to that normative database.
Dr. Ayla Wolf DAOM: 05:59
Okay. And then the neurocatch gives the brain a specific auditory stimuli and then measures the brain's electrical response to that stimuli. Is that correct? You got it. Yep. Okay. And then you're measuring the amplitude and the latency in three different parts of the brain as well. And so can you talk a little bit about uh what the difference is between the three different regions you're assessing, why you picked those, and then the difference between what does the amplitude of the signal tell us versus the latency of the signal?
Dr. Ryan D'Arcy: 06:34
Sure. Yeah. And it's it's we don't add we measure three different responses, not necessarily three different parts of the brain. And so if I just back up a little bit, the way I think of uh functional brain imaging is uh very similar to like how we look at weather systems. So our our brain activity is both exists in both spatial dimensions, so where, but it also exists in in temporal dimensions when your brain is processing. And neurocatch focuses more on the temporal
Dr. Ryan D'Arcy: 07:05
uh domain. So when you get a neurocatch exam, we'll put a an EEG cap on your head with only five sensors. So the sensors go right down the midline, and um it it actually goes on pretty quick. We can we can have the cap on and and be ready to test within a minute. And uh then what we do is we actually put um we could do it anyway, because it's often asked because you do it visual, but we we use um earbuds and and go with the auditory modality because it's truthfully kind of easy um and it gets us the responses the fastest clinically uh that we need. The three responses are actually the three most well-established uh responses for for these evoked potentials uh for measuring cognition. So if you kind of if you step back and you imagine you're inventing it, right? Take the journey. If if you're if you're sitting there saying, okay, well, we have to take this incredible literature that's looked at these uh evoked and event-related potentials, published now to date, I think it's over 170,000 papers in worldwide, right? So lots and lots of work on this. But you need to pick a small number that cover how our brain, this amazing supercomputer, processes information from low level to mid-level to high level. So those responses are um this auditory sensory response, which is uh called the N100 scientifically. And what it actually is is uh if we play beeps in those headphones, every time that beep goes from your ear to your primary auditory cortex, we can record an N100 response. So we can tell in terms of central auditory processing that that was registered at a sensory level. And then uh there's really a lot of research that if if you get a rare, an unexpected beep, a louder beep, for instance, that's surprising, you'll get this attentional switching. It's called the P300. And that's telling you that your brain is doing basic attention. I often sort of say it's like if you're walking in the woods and you hear a stick snap and you're wondering, is that a bear or a hiker, right? You're orienting if you're informing processing. So we we at our middle level, we get this P300 basic attention response. And then at the highest level, we actually use the the beeping stimuli to set you up for a pair of words. And the words uh will either fit or match, like something like bread and butter, where those two they live in the same neighborhood. We all intrinsically go, Oh, yeah, those are kind of common. Uh, but when we violate that, uh, when we say something like um bread and plant, right? Or bread and um cement, we we automatically, our brain kind of crystal balls the future and says, wait a minute, I heard bread. I was expecting butter. I um when cement came in, I was like, that just does not live in the same neighborhood. And so we we kick off this cognitive response called the N400. And so from that cognitive response, we also can tell at a higher level about cognitive processing and cognitive prediction, which is a very high-level function. So what Neurocatch does is it it basically automatically uh stimulates those three responses, puts them into a standard medical report where it ranks the responses uh because the brain waves in terms of the size, the amplitude, and the speed, the latency. So we get six measures. Three times two is six, and we put that on actually a an uh what we call a radar plot where we can look at a normal pattern, just like 120 over 80. So effectively, what I've just walked you through is how we figured out how to get a vital sign for your brain function.
Dr. Ayla Wolf DAOM: 10:53
Right. And so in the case of people that have
Dr. Ayla Wolf DAOM: 10:55
had concussions, brain injuries, what would you say are the most common findings? Is it that there is both a decreased amplitude of response as well as increased latency to the way that the brain is reacting to these different, whether it's a beep or two words that just don't really go together?
Dr. Ryan D'Arcy: 11:14
Well, yeah, now you're getting into the really interesting stuff because uh my work had connections to the Mayo Clinic, which was doing a lot of work in concussion, isopy concussion in particular in Rochester. And they were, they were doing, uh, they were getting frustrated because all the measures were subjective and they wanted something that was objective and physio, neurophysiological. So they started it the early days before neurocatch was even neurocatch, it was a prototype. Um, we started doing a lot of research looking at acute concussion. And no one in the world had ever created a portable device that could actually look at your brainwave changes immediately after a acute concussion. And by that I mean in the dressing room, right? Like rinkside. And and so what we saw was quite fascinating because these uh responses, these three responses, in the immediate time range of early first 24 hours, your their responses would get larger and slower. All three of them. And you're taking my word for it. When when they're slower, it's like running the hundred meter sprint slower, they're just slower. And when they're the when the amplitude or the response size changes, what drives that is the number of pyramidal cells in the cortex that fire in synchrony. So to sort of make that even more simple, activation in your cortex, the amount of cells that are firing together, creating activation. So immediately after that, we knew in the first 24 hours, the brain, based on its physiology, was recruiting more cortex to do the same job slower. And that was the profile of an acute concussion.
Dr. Ayla Wolf DAOM: 13:17
Uh can I ask a question on that? Yeah. Does any of that have to do with the immense release of glutamate that happens right after a concussion that makes neurons closer to threshold of firing?
Dr. Ryan D'Arcy: 13:30
I'm sure the that I would bet the activation level increase is. Yeah. And and we could theorize around kind of like the evolutionary significance of if you if you insult the brain, what's its recovery capability? Right. So so you, you know, it makes sense that it it might bring in more resources to be more active because the system has been basically compromised, um, but it's still going to go more slowly. And at the sort of neurotransmitter level, that could absolutely be what we know as excitotoxicity, but originally was, you know, intended to be adaptive and and allow for a little more activation uh to overcome the impact, right? Um, that's all, I think, really interesting science that could be done.
Dr. Ayla Wolf DAOM: 14:20
And it it almost kind of makes you just philosophize on, again, biology and why are we wired the way we're wired. And it might make sense that if we are in some kind of horrible accident, that there are systems in our body that allow our brain to be able to,
Dr. Ayla Wolf DAOM: 14:35
like you said, kind of recruit additional uh neuronal pools to all fire to maybe get us out of danger uh after a head injury if we need to. I don't know. It's a fascinating topic to explore.
Dr. Ryan D'Arcy: 14:47
Yeah, it's it's interesting because one of the things about being able to get to the front line and ask those questions that haven't been answered, the scientific establishment is not keeping up, right? So when we published that paper, we got um people saying, well, wait a minute, shouldn't the responses all be smaller and delayed? And we just made the simple point that no one had ever looked in the early acute phase. It turns out that if you move so much as even another 24 hours and you start to see that. And there's a course of our neurophysiological recovery that you can track, but only when you can monitor it easily with something that's a device that isn't uh, you know, one of my high-field MRIs that I've used throughout my career.
Dr. Ayla Wolf DAOM: 15:32
So you're saying somebody walks out of an MMA fight, has the neurocatch done right after, it's going to be very different right then versus when you do it 24 hours later.
Dr. Ryan D'Arcy: 15:45
Absolutely. Yeah. And and it's actually, it was interesting because uh the way our the path our research and our studies took became a little bit unpredictable because we didn't expect to be that whoppingly sensitive to acute concussion, but it was actually really glaringly clear on the scans. So we then actually, just as inquisitive scientists, we we had said, well, we have these teams that a large proportion of them hadn't got a diagnosed concussion. But they did have sensors on their helmets. So we knew how much impact they saw over the course of the season. We had that quantified. So we just asked the simple question is there a difference before and after the season in terms of their cognitive processing and their and their sensors? And not surprisingly, there is. Um, you do you sort of accumulate contact exposure over the course of a contact sport, hockey, football, MMA, what have you. But what we saw was a systematic um cognitive slowing in the N400 latency, um, and quite quite pronounced in the extreme cases. So it was, it was it was linearly and very significantly correlated to how much exposure you saw would be how much your cognitive brain function was delayed. And so that was kind of where we started to look at, okay, let maybe we're sensitive enough to not even need to operate at the concussion level, but at the exposure to concussive impact level. We did a ton of studies in football, um, MMA, uh high school sports, contact sports, non-contact sports. Uh, and and the common, common result that comes out is this N400 response is sensitive to your concussive impact exposure.
Dr. Ayla Wolf DAOM: 17:35
And so this device is basically, in a sense, kind of catching changes in brain physiology, regardless of whether or not somebody's symptomatic, like in terms of saying, I'm dizzy, I'm nauseous, I have headaches. Um, this is picking up changes in the brain based on kind of the amount of subconcussive
Dr. Ayla Wolf DAOM: 17:56
hits to the head that somebody has experienced in their sport during a season.
Dr. Ryan D'Arcy: 18:01
Correct. It's very sensitive to cognitive impairment, uh, right down to just the timing of that N400 response as kind of a like a window of green, like safe area, uh, an area of concern, a your yellow light, if you will, and then a red light area, which is clearly cognitive impairment. And uh, we're now actually flipping the script in a bunch of ways. We're actually using that data for performance. So um we're actually uh it turns out our cognition is very dynamic in and affected by a number of things. And you can actually move the cognitive response faster on an average of about 75 milliseconds faster. So now you can imagine if let's say you're a uh quarterback in football, and you know that your your N400 is right at 400 milliseconds, which is the kind of the average, that's the 400 number. But we've now moved you to 350. So you're now 50 milliseconds faster. What does that mean? It means that you can read patterns and anticipate things 50 milliseconds faster. So you can anticipate the play uh in terms of like a comparison to Tom Brady reading patterns and connecting passes, but you can also anticipate when you're in the pocket the incoming hit and move uh so that it's not a career-ending hit. So imagine now you're talking about prevention through performance. But if you don't measure, let's say you just leave that quarterback unmeasured throughout the season, and we know that they're exposed to a certain degree of tackles and hits and and there's just contact accumulating, that timing can slide so much as 150 milliseconds. So instead of being 350 milliseconds, you're now 550 milliseconds. That's a 200 millisecond um delay uh for seeing the incoming hit that that could end your career. So the world that I see now is really a more positive one of in medicine you can't treat what you can't measure. So if you can measure it, you can actually start to optimize someone and keep them out of dangerous concussion zones.
Dr. Ayla Wolf DAOM: 20:26
And so I know when people are measuring saccade latencies, the latency like normal is around 200 milliseconds. And then you have people that have had concussions, brain injuries, their saccade latencies might be 400. So it's interesting that these numbers all kind of match up. And you had mentioned that you could measure these uh evoked potentials in the brain using the visual system as well instead of auditory, but auditory is just easier. Is that what you're saying, where you would actually be giving people different lights and they'd have to look at it and you'd be measuring the evoked potentials?
Dr. Ryan D'Arcy: 21:03
Um, yes, you could you can absolutely do that. The evoked but the all three of these responses you can get through visual stimulation. So you can get an N100, a P300, and an N400 visually. We published the paper to show it. Uh, they they will effectively perform the same thing. The interesting part uh that I've always sort of reframe things is when we talk about objective measures, we're it to me, it was intuitive to talk about neural processing as a measured brainwave because that's a a measure of your cognitive processing direct. Um when you look at uh let's say psychadic eye movements, they too get disrupted. So as a clinician, if you have uh uh data from neural catch and you have data from psychadic eye movements, then yes, you're Probably increasing your confidence that what you're looking at is a concussive impact.
Dr. Ryan D'Arcy: 22:05
The difference where neurocatch comes out is you could have an acute concussion and you could have some psychadic changes. And then you start worrying about things like CTE. And when we do a neurocatch, we can sometimes decouple and say, listen, yes, you were impacted, but from a cognitive function standpoint, you're actually still in healthy range. So a lot of clinicians that use neurocatch, one of my favorite ports that come back from the field is that they get uh clients and and patients crying because they were actually under so much anxiety that their cognition was impacted and that they they read about CTE, they were worried about dementias and depressions. And the neurocatch is the first objective confirmation that says, yes, you did have a concussion, but thankfully we're not entirely concerned about your cognition, right? So let's focus on if your psychotic eye movements are causing um problems like headaches or or you know double vision or or you know, you've got balance and vestibular problems. And so it's allowing us in in some ways, I think in our clinic, because I I run, we we have a clinic uh that works in uh concussion as well, uh, it's allowing us to really better tease out where we need to focus our efforts on in those cases.
Dr. Ayla Wolf DAOM: 23:23
Yeah. So that kind of leads into the other question that I had, which is let's say you've got a football player, you test them at the end of the season, their N400 is 550 instead of 400. If they then take three months off and don't uh, you know, practice or take any kind of hits to the head during those three months, then do you see improvements happen? Like, are you seeing a reversal of the damage accumulated during peak season?
Dr. Ryan D'Arcy: 23:53
Bunny, you should ask. So we did this in one of my favorite studies ever with a high school where the high school students uh were uh did the science, collected the neurocatch data, were on the publication with our male colleagues. So, like published in a very prestigious journal. And we scanned looking at contact and non-contact sport and could show the subconcussive difference. Uh, we could actually also show differences in the brain vital signs between female athletes and male athletes, which is a long-standing area that needs a whole lot more uh evidence based in it. Um yeah, I will. The short version is um uh the female athletes have larger responses across basically all three responses. They have larger responses uh in baseline scanning than the males do.
Dr. Ayla Wolf DAOM: 24:46
You mean the larger amplitude?
Dr. Ryan D'Arcy: 24:48
Larger amplitude in the N100, P300, and N400, yeah. And significantly larger. So females have a unique brain vital sign profile relative to males.
Dr. Ayla Wolf DAOM: 25:00
And you're talking about like healthy, non-injured females.
Dr. Ryan D'Arcy: 25:04
Yes, correct. And they were both actually equally impacted and subconcussive. Uh, and we now have some data that shows that that's actually similar and concussive. Um, but here's the interesting part to your question. We're writing out the second paper to follow now because these students go home for summer and then they come back. So we would measure them before and after contact sport and then actually do another assessment when they got back after a break in a summer. And um, without uh obviously going too deep into the science because I don't want to spoil the paper, but uh they recover back.
Dr. Ayla Wolf DAOM: 25:40
Okay. So there's there's uh objective evidence to say that your brain is recovering during these downtimes.
Dr. Ryan D'Arcy: 25:49
Correct.
Dr. Ayla Wolf DAOM: 25:51
Which is very good news for people to hear.
Dr. Ryan D'Arcy: 25:53
Yeah. Yeah, we've got some really neat um at the time I'm giving like we're doing this podcast, we got some cool results that are like hot off the presses but not published yet. So that's one of them. Uh the other one is that we have studies uh through uh the our our collaborators with professional rugby in Australia that is showing that the N400 latency um systematically delays. So these are rugby players that we had baselines on, and then they had a concussion and we scanned them at day two, day 10, um, at which was the mandatory return to play date, and then um day 42 when they were later on in the season.
Dr. Ryan D'Arcy: 26:35
And there we have the first trajectory of the full recovery of concussion. And at day two after concussion, they have a significant delay in the N400 latency. And by day 10, which was the mandatory minimum for the this league for return to play, they were back to uh baseline levels. So that's pretty fun. Yeah.
Dr. Ayla Wolf DAOM: 26:57
Yeah. And uh are you in the process of writing this up and and submitting it to journals?
Dr. Ryan D'Arcy: 27:03
I was literally working on the manuscript right before I jumped on this podcast.
Dr. Ayla Wolf DAOM: 27:08
Awesome. So literally hot off the press.
Dr. Ryan D'Arcy: 27:11
Yes. Yeah, it's it's still in the press. Yeah. We have we have a number of interesting studies coming down. Uh we have a very, very large, uh 372 acute concussions uh being being published. And in short, without spoiling any of those results, I'll tell you that the results that we are seeing are very robust. Um, and the N400 is turning out to be very, very sensitive to cognitive impairment, uh subsequent or secondary to a concussive impact.
Dr. Ayla Wolf DAOM: 27:41
And then I'm assuming you've got a lot of clinics. I'm actually I've been talking to somebody at Neuropeak, and so I know that they use Neurocatch all the time to be able to assess their patients during rehab. And so one of the things that um Matthew said that was really interesting is that sometimes people, how did he phrase it? Um it's almost like their brain function is improving, and yet their ability to like go back to work and do all the things that they used to do, they're they're still not able to accomplish that. And there's kind of this um mismatch between the two of like, okay, you know, all of your tests are are looking normal, your capacity is there, but your ability to actually like put that into day-to-day life is somehow not translating.
Dr. Ryan D'Arcy: 28:34
Yeah. So at Neuropeak, we specialize in um post-concussive syndrome and chronic concussion and very complex concussion cases. And uh there, the heart of it is the fundamental concept of neuroplasticity. And so what we're what we're really focusing on is um, I think the theoretical way that I've come to think about neuroplasticity in all the years I've worked um seeing it in action is that it's a biological property that's in essence in our brain, whether we like it or not, right? My quick version of operational description of neuroplasticity is your brain's innate ability to rewire new circuits to recover function or to drive function. I think what you're describing in terms of what Matthew is talking about is that I sometimes, when neuroplasticity is in our brain, if you don't like direct it, it can have a maladaptive impact. Right. So you can recover your balance or your vestibular function or your cognitive function. And if you've had a concussive impact longer than you thought, you could have actually started to wire some new circuits around being anxious or feeling like you're not yourself or feeling brain fog. And that's neuroplasticity working in a maladaptive way. But as clinicians, one of the things we can do is actually grab the tiger by the tail and help uh empower clients and patients to say, I'm gonna use neuroplasticity towards what I want. So when we do in clinic, we'll set goals and we'll say, what is it that really matters to you? What, what, what functional recovery goal do you want? And then we'll actually drive the neuroplasticity in a focused way, just like an athlete trains to rewire those circuits to recover those functions. And often it might not be balance or it might not be cognitive rehab we're doing. It might be uh, it might be mood, it might be attention, um, it it can be a host of things. So I think the heuristic approach uh to post-concussive syndrome is critical when it's grounded in the fundamental science of neuroplasticity.
Dr. Ayla Wolf DAOM: 30:53
A lot of times if somebody is, say,
Dr. Ayla Wolf DAOM: 30:55
sitting there and just doing one single eye exercise, but their brains already learned some kind of compensatory compensatory mechanism for doing that, then repeatedly doing that one thing is just kind of reinforcing maybe that maladaptive compensation. And so a lot of times the trick is to pull in all these other things that you have to do at the same time to get your brain to figure out a new way of doing that eye movement that isn't just creating the plasticity in the pathway that you don't want. And so it sounds like what you're speaking about is the same thing where it's like the brain capacity might be there, but we've got these kind of maladaptive compensation strategies that are now kind of hardwired in, then we need to like uncouple those and um create some new ways of the brain to process doing things.
Dr. Ryan D'Arcy: 31:49
Exactly. So one metaphor that I love is the trailblazing metaphor. We if you imagine a grassy field and you beat down a trail, then it's always easier to go down that trail. But from a clinical standpoint, if you don't want to end up in the same place you always end up in at the end of that trail, you have to blaze a new trail. And so what you can do clinically is help first identify where is it you want to go, and then let's get you the trail to get you there. And then we just start beating down a new trail. And that's rewiring those circuits, right? And that's fundamentally neuroplasticity.
Dr. Ayla Wolf DAOM: 32:26
Yeah. And the metaphor makes sense, but putting that into practice in all the different possible combinations for every individual person is where things get really complicated.
Dr. Ryan D'Arcy: 32:38
Yeah, I I would say uh on the surface, yes. But in reality, no. Okay. Um, I I've, you know, my most probably sort of well-known case is the the soldier attacked in a in Afghanistan with an axe to the top of his head, where it's uh the axe injury, the the attack, um, the axe went and transected the body, the corpuscum also. So I don't, I don't believe there's an official recognition of it, but he unofficially has the largest surviving brain injury on the planet. And I've been able to use these concepts to drive unprecedented um recovery in in, well, he used these concepts to drive unprecedented recovery. Um many, many years, he was attacked in 2006. So we're 20 years later and he's still making gains. So I think, I think that the moral that the lesson I took from that story was he had a very focused goal. So if his goal in his case, because where the injury was, knocked out a lot of the motor function for particularly for lower limb motor function. So his goal was to stand and to be able to not be wheelchair bound. Um, and and so we really just focused on that goal. And and and then if that's your clothesline, you're pinning all your therapeutic capabilities towards that single goal. So we've we you know, we moved through different things. He was doing intensive rehab himself. I mean, it's a lot of work. So I think that's one of the biggest challenges is people who want quick fixes to a brain injury. I I don't I think our job is to manage their expectations. Our job is to tell them that this is this is you can get it, but it's gonna be a lot of work. And um so we we would do rehab and then we moved to uh the ponds neuromodulation, which was incredible. It's the biggest gains I've ever seen in in my clinical life and probably ever will.
Dr. Ayla Wolf DAOM: 34:33
Um and for the listeners, that's the high the tongue stimulation device.
Dr. Ryan D'Arcy: 34:38
Transvenual, yes, transringual neurostimulation. Yeah. So we worked a lot with that device and neuromodulation is is really impressive.
Dr. Ryan D'Arcy: 34:45
Um it's just not as accessible as it needs to be. So, you know, I think it will be so increasing in time. But when you pair that with therapy, it it has dramatic effects and it did. Um, so I think, you know, then we move to whatever problems were getting in the way of his goal. Um, whenever there was a problem, we just focused on that problem. But that's why I think, yes, it's super complex. Um, but when you have a a very, when a when a patient or a client has a very focused goal and they're gonna, they're dedicated to work towards that, then you you can see a lot of incredible change.
Dr. Ayla Wolf DAOM: 35:20
Yeah. And it's always amazing when you can speak to somebody who basically had an injury that's 20 years old and they're still telling you, I'm seeing improvements after all of this time. And I think that's such a powerful message for people to hear, especially when they're early on in their recovery and you know, they feel like progress is slow.
Dr. Ryan D'Arcy: 35:40
Yeah. Well, and we published um a good number of these studies. So uh for those listeners, you can you can read the papers. And my favorite part about those papers is both um this individual and his wife are co-authors on the paper. So they ended up revolutionizing the science through their recovery, right? So so I I would I would say I always think of neuroplasticity neuroplasticities synonymous with hope. Like it's the way to empower hope in a patient to just help them understand it's in there, it can operate unchecked, or you can you can direct it and and find ways to regain function. Uh and yes, it's hard work, but if you put the work in, uh you will see gains.
Dr. Ayla Wolf DAOM: 36:28
Yeah, yeah.
Dr. Ayla Wolf DAOM: 36:30
Um but what can't neurocatch tell us perfect.
Dr. Ryan D'Arcy: 36:36
Yeah. So neurocatch, a lot of people will think, oh, it's an EEG. It's it's a much more powerful, it's derived from EEG, but it it talks about the specific aspects of of these functions, sensory, attentional, and cognitive. So it's it's very focused on those things. So it it we we don't do a lot of work in like um neural feedback and changes in in different frequency states. Um we because we stimulate through the auditory modality, um, for sure, in a concussive impact with a visual, like a primary visual or or secondary visual uh sequali, we we wouldn't necessarily be sensitive to that. If it impacted cognition, we would. Uh, but uh it was never intended to be um sort of uh be all an end-all. It was intended to give you the best sensitive and specific measure of cognitive function. So if you have a question about balance or gait or anxiety, um if it indirectly affects cogn cognition, then we can we can tell you. It's it is interesting because um we're really starting to understand the clinical significance of the responses. Uh the N100, the auditory is central auditory, so things like tinnitus, for instance, will affect that. Um the P300, as it turns out, is incredibly sensitive to uh arousal level and things like PTSD. So we do a lot of work in veterans and first responders, and we're teasing out the concussive impact from this sort of more of the PTSD type of responses by looking at the P300 from a an arousal level perspective, and then looking at the N400 from a cognitive impairment perspective. So it it it can tell you more than I expected it can, but it definitely has a swim lane.
Dr. Ayla Wolf DAOM: 38:26
Mm-hmm.
Dr. Ayla Wolf DAOM: 38:27
Yeah. But what sounds amazing about it is like you said, you can set it up, you can put the cap on, have that ready to go in a minute, you can do the test in six minutes when you're needing to get an immediate answer on how is their cognition doing immediately after a concussion or within the first one day, two day, 10 days. This sounds like it could be very informative.
Dr. Ryan D'Arcy: 38:50
Yeah, we we really focused on accessibility and that that was more of a techno technological um sort of advance than it was the science was already established. So where clinically it's useful, um certainly in the early intakes, particularly triaging for more extensive cognitive
Dr. Ryan D'Arcy: 39:10
assessment, it's it's useful. Clinicians use it for that. They they're the by far and away the big, the big area that all clinicians tend to use it, and and that's monitoring. So you can do a number of neurocatch scans um in one uh patient visit or cross-patient visits. So a lot of treatment monitoring. Um, whether or not you're trying something like medications or you're looking at um even post uh exercise activation, we see differences. A lot of people look at it for things like um photobiomodulation, uh, hyperbaric oxygen therapy. Um what else have we seen? Obviously, neurostimulation, transgranial magnetic stimulation, uh peptides um and and supplements. So it's it's very sensitive. So clinicians use it a lot to see if if the treatment interventions you're using are actually moving the dial or not.
Dr. Ayla Wolf DAOM: 40:02
Um, regardless of what that intervention is, um, people are using it to track.
Dr. Ryan D'Arcy: 40:08
Yeah. The the the land speed record for a neurocatch comes out of Australia. Um bum and chair to report in doctor's hands in eight minutes and 30 seconds. So it is, you can do it quickly. Uh we have we have people who use like have 10 devices and and have collected um data from 150 people in four hours. Uh so you can you can scan a lot of people um uh or you can scan one individual a lot of times.
Dr. Ayla Wolf DAOM: 40:36
Yeah, and are you are they using it in the context of like getting a reading and then doing reaction time training and then doing it again?
Dr. Ryan D'Arcy: 40:44
Yes, probably the fastest sectors that have taken it up are pro sports and military, special forces. So we have um we have a lot of really interesting stuff going on uh in hockey, uh basketball, uh, football, MMA, uh some now uh motorsports, a lot of Red Bull mountain biking. Um and athletes are basically using it to think faster. They they've got to a place, there's a kind of a shift in that everyone's wrapped their head around physical optimization. And so they're now looking for the advantage, everything's down to milliseconds matter. And so they're looking for can they anticipate faster? Um, and can they keep themselves in terms of heavy travel schedules or the wear and tear of a season? Can they keep themselves in the sweet spot? And so so there's a lot of neurocatch scanning there where we're investigating the things I just mentioned that are actually optimizing you. Um, executive health is the same thing, actually, a lot of uptake in executive health to optimize how fast they're thinking. So, so I think the power is um there's so much out there and you can't really find what you should, what really moves the dial. And so people are really finding that they just do a pre- and post-neural catch, and the thing they think moves the dial, they're gonna find out if it does or it doesn't. And and more often than not, in performance, the idea is can I move the dial faster? Because that's the motivating factor.
Dr. Ayla Wolf DAOM: 42:09
Yeah. And you mentioned medications and supplements. Are you seeing if somebody is on, say, an ADHD medication, uh, are you seeing certain very clear patterns in function based on what types of medications people are on?
Dr. Ryan D'Arcy: 42:25
Yeah, we haven't done um we haven't done rigorous research on this. Like there's no published science. And um, we haven't done a ton of like cases, but the one that always sticks out in my head is someone who was on Adderall for ADHD and scanned herself um before she'd normally take the Adderall, and then two times after. And you might expect that the attentional P300 was the thing that changed, but it was actually the amplitude of the N400 went up. Um, and so there was more Adderall activated, uh, more uh more activation in the cortex, more pyramidal cells firing and synchrony. And and that scan, because we we can show multi-scan where you compare uh the waveforms across. And that scan is like it's a mic drop for for physicians uh who do a lot of prescribing of medication because they've never ever seen what what actually happens uh to your cognitive brain function when you prescribe a medication. They're activating more cortex to do that job. Yeah.
Dr. Ayla Wolf DAOM: 43:26
Mm-hmm. They're they're activating more cortex.
Dr. Ryan D'Arcy: 43:29
Yeah, activating more more cortical networks to do the job. That's what the medication is doing. Um it it's it's interesting because so if we dive a little bit science deep in deeper into the N400, um your brain, in terms of being an efficient processor of information, loves to crystal ball the future and then check against delivery. And so it sounds funny because it's like, oh, they're just basic words, but these simple words testify. Fundamental principle in your brain, which is when I say the word bread, your brain has already activated the neighborhoods that it expects are likely to come next, because then it doesn't have to do the processing. It just has to check against what came in. So it can process way faster than it can transmit information when it does it that way. It's an efficiency mechanism, right? A cognitive efficiency mechanism. So so when I violate that with cement, or and we give 72 word pairs, so it's not just that, that specific. What happens is it absolutely grabs and says, wait a minute, that didn't fit. So it's it's checking the anomaly. So when you stop and you think about that a bit, um, that's crystal balling the future, right? That's what we're tapping, is the your brain's ability to predict the future and the patterns. So we did this really cool study with hockey players where we we were scanning all the junior A's uh up here in in British Columbia and Canada. They were um, we were doing it mostly for concussion, but we had a lot of data. And so we started looking at the data of what do these things map out against like points per game and all the metrics that they care about, right? They're performance metrics. Um, you get these correlation matrices, right? That tell you if there's something hot that that's correlating. Nothing correlated. It was it was like dead. Um, except this one little island right in the middle. And so we drilled in on it and it was player position. So it turns out that um forwards have faster cognitive anticipation than defensemen by an order of 60 milliseconds, like very strongly significant, because their job is to have to anticipate the openings and find where they're gonna shoot the puck and bury it in the net. Defensemen have a different job.
Dr. Ryan D'Arcy: 45:55
I'm generalizing, but in general, they have to protect the goalie and get the puck out over the blue line. So they're not necessarily reading the patterns as quickly as forwards are. And we could see that in in the neurocatch brainways. We could see that the the goalies had larger P300s, attentional responses, right? And that of course would transcend. We just had the World Cup goalies and the World Cup keepers in there would be the same. Uh, and so now athletes are like, okay, wait a minute, this really is giving me a performance advantage. But it all ties back to this well, that bread concrete or bread butter seems simple. It's tapping the brain's innate ability to predict the future cognitively. What do you think is most sensitive to cognitive impairment and concussion or dementia? Right? It's it's right in that wheelhouse. If I'm if I'm starting to slip from a concussion or I'm starting to slip from from mild cognitive impairment and dementia, my brain isn't the supercomputer it used to be. It's not predicting the future as quickly as it used to. And that's why we can get it right down to the the timing in milliseconds of the N400.
Dr. Ayla Wolf DAOM: 47:09
Right. And so essentially you use the word efficiency. So when you're seeing the N400 number get larger, in a sense, the brain is being less efficient.
Dr. Ryan D'Arcy: 47:20
Uh, it is taking longer to process the information, yes. So I'd say yes. Um, but we've won run studies with folks in care homes, and their N400s are out in the 700 range. Right? When so 300 seconds, milliseconds delayed. So so we do have an area where we know it's very impaired processing, and we can define an area where it's healthy, and we can define an area where it's a w a caution area right down to milliseconds.
Dr. Ayla Wolf DAOM: 47:54
Got it. Okay, that makes sense. All right. Well, what is next for you? I know you just won an award. Congratulations.
Dr. Ryan D'Arcy: 48:03
Yeah. Yeah. Um my job now is uh mostly focused on uh Neurocatch is a 4S bias tool. So it's really focused on supporting uh clinicians using it, um performance teams using it, um, leading continued science, uh, and and just really getting to try and understand when people are are using this tool uh the ways we can make it better.
Dr. Ayla Wolf DAOM: 48:34
Awesome. How long has it been around? How many years?
Dr. Ryan D'Arcy: 48:39
We started the research in 1995, mid-90s. Um there was a lot of research underpinning it, uh, sort of validating it against cognitive testing and neuropsych. That that moved into about 2010, um, when EEGs became increasingly portable and our our we were getting the early signs of what became AI, uh machine learning and signal processing. That moved into a portable device that was a prototype. Uh and then 2015 was the first generation of of neurocatch, and we're in our second generation, which has been out since 2021. And our third generation is in development right now. So, so it has a longstanding um kind of uh research history, and it's been out in the world as a medical device, regulatory approved for uh, well, over 10 years now.
Dr. Ayla Wolf DAOM: 49:31
Yeah, incredible.
Dr. Ayla Wolf DAOM: 49:33
And why don't you let people know where they can learn more about it, where they can find one. Do you have a clinic locator for people who use the device?
Dr. Ryan D'Arcy: 49:42
I don't think we have a clinical locator yet, but you can go to neurocatch.com and neurocatch.com will definitely uh be the the source to get connected. Um and there uh uh the the teams, myself or otherwise, can help you if you're looking for a clinic locator or you're looking to get uh get the device. That would be your best site.
Dr. Ayla Wolf DAOM: 50:06
Fantastic. Awesome. Well, this was fascinating. Thank you so much for your time and everything you're doing in allowing us to have better objective markers of brain function.
Dr. Ryan D'Arcy: 50:18
Thanks for thanks for having me. This was a lot of fun.
Dr. Ayla Wolf DAOM: 50:22
Excellent. Well, um, I will put all that in the show notes so people can learn more about neurocatch. I'll maybe link to some of those uh studies too that you had mentioned. The one with the hockey players, was that the one that was published in 2019?
Dr. Ryan D'Arcy: 50:38
It could have, it could have been. Um, a lot of the studies that I referenced, if you go to the Neurocatch website and you go under the publications tab, the Breen Vital Signs, they're all there. And they're all a couple of links. Yeah.
Dr. Ayla Wolf DAOM: 50:52
Okay. Fantastic. Medical disclaimer. This video or podcast is for general informational purposes only and does not constitute the practice of medicine or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and materials included is at the user's own risk. The content of this video or podcast is not intended to be a substitute for medical advice, diagnosis, or treatment, and consumers of this information should seek the advice of a medical professional for any and all health related issues. A link to our full medical disclaimer is available in the notes.